BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 10758616)

  • 21. Reassessment of the reproducibility of Technetium-99m mercaptoacetyltriglycine clearance.
    De Sadeleer C
    Nucl Med Rev Cent East Eur; 2005; 8(1):15-20. PubMed ID: 15977142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of 99Tcm-bicisate as a renal imaging agent.
    Ozker K; Kabasakal L; Liu Y; Hellman RS; Isitman A; Krasnow AZ; Collier BD
    Nucl Med Commun; 1997 Aug; 18(8):771-5. PubMed ID: 9293508
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Calculation of renal clearance by dynamic measurement of excreted activity].
    Hackstein N; Bauer R
    Nuklearmedizin; 1999; 38(2):43-8. PubMed ID: 10100230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overall accuracy of technetium-99m-MAG3 clearance measurements obtained with a gamma camera heart curve.
    Tondeur M; Kinthaert J; Piepsz A; Ham HR
    J Nucl Med; 1996 Aug; 37(8):1281-4. PubMed ID: 8708756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chromium-51-EDTA clearance in adults with a single-plasma sample.
    Mårtensson J; Groth S; Rehling M; Gref M
    J Nucl Med; 1998 Dec; 39(12):2131-7. PubMed ID: 9867156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal and extrarenal clearance of 99mTc-MAG3: a comparison with 125I-OIH and 51Cr-EDTA in patients representing all levels of glomerular filtration rate.
    Rehling M; Nielsen BV; Pedersen EB; Nielsen LE; Hansen HE; Bacher T
    Eur J Nucl Med; 1995 Dec; 22(12):1379-84. PubMed ID: 8586082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reproducibility of technetium-99m-MAG3 clearance using the Bubeck method.
    Werner E; Blasl C; Reiners C
    J Nucl Med; 1998 Jun; 39(6):1066-9. PubMed ID: 9627345
    [TBL] [Abstract][Full Text] [Related]  

  • 28. (99m)Tc-HEPIDA hepatic clearance as a diagnostic tool: usefulness of a single sample plasma and hepatic clearance of (99m)Tc-HEPIDA for assessment of hepatic parenchyma performance.
    Surma MJ; Frieske I; Jencz K; Kuźmierek J
    Nucl Med Rev Cent East Eur; 2006; 9(2):125-31. PubMed ID: 17304475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determination of the technetium-99m mercaptoacetyltriglycine plasma clearance in children by means of a single blood sample: a multicentre study. The Paediatric Task Group of the EANM.
    Piepsz A; Gordon I; Hahn K; Kolinska J; Kotzerke J; Sixt R
    Eur J Nucl Med; 1993 Mar; 20(3):244-8. PubMed ID: 8462614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measurement of renal function with technetium-99m-MAG3 in children and adults.
    Russell CD; Taylor AT; Dubovsky EV
    J Nucl Med; 1996 Apr; 37(4):588-93. PubMed ID: 8691246
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A single-injection, two-sample method for measuring renal 99mTc-MAG3 clearance in both children and adults.
    Russell CD; Taylor AT; Dubovsky EV; Eshima D
    Nucl Med Biol; 1995 Jan; 22(1):55-60. PubMed ID: 7735170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Technetium-99m mercaptoacetyltriglycine clearance values in children with minimal renal disease: can a normal range be determined?
    Meyer G; Piepsz A; Kolinska J; Lepej J; Sixt R; Hahn K
    Eur J Nucl Med; 1998 Jul; 25(7):760-5. PubMed ID: 9662599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Formulation of lyophilized single vial kit of N-N-Ethylene-L-Dicysteine (EC) for labeling with
    Afshan A; Sohaib M; Jehangir M
    Pak J Pharm Sci; 2017 Jul; 30(4):1289-1295. PubMed ID: 29039327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative study of renal scintigraphy with 99Tcm-mercaptoacetyltriglycine and 123I-orthoiodohippurate.
    Itoh K; Tsukamoto E; Kakizaki H; Nonomura K; Furudate M
    Nucl Med Commun; 1993 Aug; 14(8):644-52. PubMed ID: 8371889
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospective validation of a single sample technique to determine technetium-99m-MAG3 clearance.
    Taylor A; Corrigan P; Eshima D; Folks R
    J Nucl Med; 1992 Sep; 33(9):1620-2. PubMed ID: 1387682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reproducibility of technetium-99m mercaptoacetyltriglycine clearance.
    Piepsz A; Tondeur M; Kinthaert J; Ham HR
    Eur J Nucl Med; 1996 Feb; 23(2):195-8. PubMed ID: 8925855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kidney function after nephrectomy for renal cell carcinoma.
    Shirasaki Y; Tsushima T; Saika T; Nasu Y; Kumon H
    Urology; 2004 Jul; 64(1):43-7; discussion 48. PubMed ID: 15245931
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal clearance of technetium-99m-MAG3: normal values.
    Russell CD; Li Y; Nadiye Kahraman H; Dubovsky EV
    J Nucl Med; 1995 Apr; 36(4):706-8. PubMed ID: 7699471
    [No Abstract]   [Full Text] [Related]  

  • 39. Residual kidney function after donor nephrectomy. Assessment by 99mTc-MAG3-clearance.
    Hamscho N; Wilhelm A; Döbert N; Menzel C; Gossmann J; Berner U; Zaplatnikov K; Scheuermann EH; Grünwald F
    Nuklearmedizin; 2005; 44(5):200-4. PubMed ID: 16395496
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Captopril-induced changes in MAG3 clearance in patients with renal arterial stenosis and the effect of renal angioplasty.
    Müller-Suur R; Tidgren B; Fehrm A; Lundberg HJ
    J Nucl Med; 2000 Jul; 41(7):1203-8. PubMed ID: 10914910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.